Publications & Presentations

Jump To:

ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.

Recent Presentations

November 2018

Bipartisan Policy Center Roundtable on Gene Therapy for Neurodegenerative Disease

Washington, DC
October 26, 2018

American Thrombosis and Hemostasis Network Data Summit

October 18, 2018

BIA UK Bioscience Forum 2018

Recent Publications

July 2018
In Vivo Article

Moving From Chronic Therapies To Cures – Creating A Pathway To Enable New Payment Models

March 14, 2018
ARM Position Paper
January 1, 2018
Journal of Managed Care Medicine

Recent Webinars

June 2018

RMAT Designation – Impact on Regenerative Medicine Sector

Gain a deeper understanding of the implications of the Regenerative Medicine Advanced Therapies (RMAT) designation and the significance of its support and advancement by the FDA in this webinar recording. Held in partnership with the Alliance for Regenerative Medicine (ARM), ARM, Informa Pharma Intelligence, and representative from Abeona, Athersys, and Enzyvant discuss the RMAT designation and its implications on the sector.

May 9, 2018
October 24, 2017

Recently Submitted Comments, Letters, Statements

October 2018

September 2018

August 2018

July 2018

June 2018